Mirabella Financial Services LLP Chemo Centryx, Inc. Transaction History

Mirabella Financial Services LLP

$1.11 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	BUY	$15.36 - $27.51 $1.32 Million - $2.36 Million	85,653 New	85,653 $2.12 Million
Q1 2022 May 17, 2022	SELL	$22.22 - $39.12 $1.2 Million - $2.11 Million	-54,040 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$18.38 - $40.5 $993,255 - $2.19 Million	54,040 New	54,040 $1.97 Million
Q2 2021 Aug 13, 2021	SELL	$9.59 - $50.88 $41,131 - $218,224	-4,289 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$49.53 - $68.4 $212,434 - $293,367	4,289 New	4,289 $220,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.